Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter pumps new life into haemodialysis offering with $4bn Gambro buy

This article was originally published in Clinica

Executive Summary

Baxter International has agreed to acquire haemodialysis specialist Gambro for SEK26.5 billion ($4.0 billion) in cash and debt, confirming recent media speculation. The deal gives Baxter a “comprehensive dialysis product portfolio, complements [its] global home dialysis offerings, and positions the company to better meet the evolving needs of the large and growing dialysis market”, the company stated.

Topics

UsernamePublicRestriction

Register

MT099725

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel